I understood and received it that way, and if we need more time later on, we'll certainly get together.
I appreciate the question, because we're all interested in trying to handle health care costs. I have to say, though, that the figure you were using is unfounded. It is based on all kinds of false information; no country in the world uses weak IP to try to control health care costs. There are other ways to do it, and our industry is very interested in partnering with Nova Scotia and other provinces to work at the whole sustainability issue.
I believe it is through better use, etc., but this number that's been floated around has been discredited by a number of other studies, and we can submit them and the government folks can study them and you can come to your own conclusion. This whole notion that prices will skyrocket...this has been done in the 1980s and 1990s, and history has proven that wrong. It hasn't, and on top of that, in Canada we have a pricing review board that controls our prices. Generic companies aren't controlled, but we are.
Ultimately there has to be room for both of us. We have to create a stable environment for innovation. You said you support innovation. We have to be able to build that so our universities, our research communities, and our health care system can benefit from it, but at the end of patents, generics can move around. It is not us and them. It's if we can get the total package together, Canada can soar.